Remove Congenital Heart Disease Remove Heart Disease Remove Pediatrics
article thumbnail

Cardiopulmonary Exercise Test Interpretation Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association

Journal of the American Heart Association

Journal of the American Heart Association, Ahead of Print. Survivorship from congenital heart disease has improved rapidly secondary to advances in surgical and medical management. This is an updated report of the American Heart Association's previous publications on exercise in children.

article thumbnail

Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System

DAIC

6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).

article thumbnail

Case Report: A new therapeutic option for a rare patent ductus arteriosus child complicated with pulmonary artery aneurysm due to infectious endocarditis

Frontiers in Cardiovascular Medicine

Patent ductus arteriosus (PDA) is one of the most common forms of congenital heart disease (CHD). In this report, we report a rare pediatric PDA case, complicated with PAA due to IE. Infectious endocarditis (IE) is a rare but serious complication of PDA.

article thumbnail

PO-05-196 NURSE PRACTITIONER LED MRI CIED MONITORING IN PEDIATRIC AND ADULT CONGENITAL HEART DISEASE PATIENTS

HeartRhythm

Recent evidence shows minimal risk of MRI in pediatric and congenital heart disease (CHD) patients with cardiac implantable electronic devices (CIEDs), even with MRI non-conditional devices or epicardial and/or abandoned leads.

article thumbnail

AP-499655-002 TIME ANALYSIS FOR IN PERSON PEDIATRIC AND ADULT CONGENITAL HEART DISEASE CARDIAC IMPLANTABLE ELECTRONIC DEVICE CARE

HeartRhythm

A previously published algorithm calculates recommended Full-Time Equivalent (FTE) needs for Cardiac Implantable Device (CIED) clinics, but does not account for pediatric patients (pts) and adults with congenital heart disease (ACHD).

article thumbnail

The impact of pre-transplant ventricular assist device support in pediatric patients with end-stage heart failure on the outcomes of heart transplantation—“a single center experience”

Frontiers in Cardiovascular Medicine

In light of the limited availability of donor organs, particularly in Europe, the number of children requiring ventricular assist device support is rising at an unavoidable rate.MethodsWe performed a retrospective cohort study of patients who underwent a single and primary pediatric heart transplantation.

article thumbnail

PO-01-024 A LARGE, SINGLE CENTER EXPERIENCE WITH FLECAINIDE THERAPY FOR FOCAL ATRIAL TACHYCARDIA IN PEDIATRIC PATIENTS WITH CONGENITAL HEART DISEASE

HeartRhythm

Use of flecainide is well-described for focal atrial tachycardia (FAT) in adult patients without structural heart disease. However, its application in pediatric patients with congenital heart disease (CHD) and FAT remains limited.